HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA) / Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Tridenti, G., Vezzani, C., Fulghesu, A.m., Madeddu, E., Amarri, S., Street, M.. - In: GYNECOLOGICAL ENDOCRINOLOGY. - ISSN 1473-0766. - (2020).

HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)

STREET M
2020-01-01

2020
HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA) / Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Tridenti, G., Vezzani, C., Fulghesu, A.m., Madeddu, E., Amarri, S., Street, M.. - In: GYNECOLOGICAL ENDOCRINOLOGY. - ISSN 1473-0766. - (2020).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2905096
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 33
social impact